Nanoview Biosciences

Provider of a nanotechnology based molecular diagnostic platform

placeBoston, Massachusetts, United States calendar_todayFounded 2015 groups24 employees language nanoviewbio.com

Registered entities

Innovation

5 patent families (2 granted) — focus: Physics & computing; filing pace slowing. Cited 420 times.

YearFilings
20181
20192
20203
20213
20222
20241

Investor mix

6 investors on record; lead investors include Northpond Ventures; 1 has since exited.

Investor typeCountShare
Venture capital350%
Private equity117%
Other / undisclosed233%
Coming soon